{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:21:45Z","timestamp":1755800505408,"version":"3.44.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,20]]},"DOI":"10.7759\/cureus.90552","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T09:31:05Z","timestamp":1755682265000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Oral Dydrogesterone in Improving Neonatal Birth Weight Outcomes in Idiopathic Intrauterine Growth Restriction: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Nadira","family":"Kasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseeb","family":"Nama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060501","article-title":"Intrauterine growth restriction: need to improve diagnostic accuracy and evidence for a key role of oxidative stress in neonatal and long-term sequelae","volume":"13","author":"N\u00fcsken E","year":"2024","unstructured":"N\u00fcsken E, Appel S, Saschin L, et al.. Intrauterine growth restriction: need to improve diagnostic accuracy and evidence for a key role of oxidative stress in neonatal and long-term sequelae. Cells. 2024, 13:501. 10.3390\/cells13060501","journal-title":"Cells"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00055","article-title":"Neonatal morbidities of fetal growth restriction: pathophysiology and impact","volume":"10","author":"Malhotra A","year":"2019","unstructured":"Malhotra A, Allison BJ, Castillo-Melendez M, Jenkin G, Polglase GR, Miller SL. Neonatal morbidities of fetal growth restriction: pathophysiology and impact. Front Endocrinol (Lausanne). 2019, 10:55. 10.3389\/fendo.2019.00055","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102729","article-title":"Perinatal and neonatal outcomes in fetal growth restriction and small for gestational age","volume":"11","author":"Lubrano C","year":"2022","unstructured":"Lubrano C, Taricco E, Coco C, Di Domenico F, Mand\u00f2 C, Cetin I. Perinatal and neonatal outcomes in fetal growth restriction and small for gestational age. J Clin Med. 2022, 11:2729. 10.3390\/jcm11102729","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2021.10.016","article-title":"Progesterone partially recovers placental glucose transporters in dexamethasone-induced intrauterine growth restriction","volume":"44","author":"Alawadhi M","year":"2022","unstructured":"Alawadhi M, Mouihate A, Kilarkaje N, Al-Bader M. Progesterone partially recovers placental glucose transporters in dexamethasone-induced intrauterine growth restriction. Reprod Biomed Online. 2022, 44:595-607. 10.1016\/j.rbmo.2021.10.016","journal-title":"Reprod Biomed Online"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/02601060241299010","article-title":"Impact of iron-folic acid supplementation on maternal and neonatal outcomes: a systematic review & meta-analysis","volume":"31","author":"Srivastava M","year":"2025","unstructured":"Srivastava M, Gulia A, Upadhyay AD, Patel KK, Sankar MJ, Sinha A, Kumar P. Impact of iron-folic acid supplementation on maternal and neonatal outcomes: a systematic review & meta-analysis. Nutr Health. 2025, 31:81-90. 10.1177\/02601060241299010","journal-title":"Nutr Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-023-06916-x","article-title":"Dietary intakes of iron, folate, and vitamin B12 during pregnancy and correlation with maternal hemoglobin and fetal growth: findings from the ROLO longitudinal birth cohort study","volume":"309","author":"Rooney DJ","year":"2024","unstructured":"Rooney DJ, Conway M, O'Keeffe LM, et al.. Dietary intakes of iron, folate, and vitamin B12 during pregnancy and correlation with maternal hemoglobin and fetal growth: findings from the ROLO longitudinal birth cohort study. Arch Gynecol Obstet. 2024, 309:183-93. 10.1007\/s00404-023-06916-x","journal-title":"Arch Gynecol Obstet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051967","article-title":"Increased live birth rate with dydrogesterone among patients with recurrent pregnancy loss regardless of other treatments","volume":"12","author":"Bashiri A","year":"2023","unstructured":"Bashiri A, Galperin G, Zeadna A, Baumfeld Y, Wainstock T. Increased live birth rate with dydrogesterone among patients with recurrent pregnancy loss regardless of other treatments. J Clin Med. 2023, 12:1967. 10.3390\/jcm12051967","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-03562-6","article-title":"Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo-controlled trial","volume":"21","author":"Thongchan S","year":"2021","unstructured":"Thongchan S, Phupong V. Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo-controlled trial. BMC Pregnancy Childbirth. 2021, 21:90. 10.1186\/s12884-021-03562-6","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2022.03.032","article-title":"A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis","volume":"45","author":"Katalinic A","year":"2022","unstructured":"Katalinic A, Shulman LP, Strauss JF, Garcia-Velasco JA, van den Anker JN. A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis. Reprod Biomed Online. 2022, 45:365-73. 10.1016\/j.rbmo.2022.03.032","journal-title":"Reprod Biomed Online"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241044","article-title":"Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: a systematic review and individual participant data meta-analysis","volume":"15","author":"Griesinger G","year":"2020","unstructured":"Griesinger G, Blockeel C, Kahler E, Pexman-Fieth C, Olofsson JI, Driessen S, Tournaye H. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: a systematic review and individual participant data meta-analysis. PLoS One. 2020, 15:e0241044. 10.1371\/journal.pone.0241044","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-024-07069-8","article-title":"Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial","volume":"24","author":"Rinaldi L","year":"2024","unstructured":"Rinaldi L, Crescenzi F, Selman H. Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial. BMC Pregnancy Childbirth. 2024, 24:845. 10.1186\/s12884-024-07069-8","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-024-01322-7","article-title":"Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?","volume":"22","author":"Lorillon M","year":"2024","unstructured":"Lorillon M, Robin G, Keller L, et al.. Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?. Reprod Biol Endocrinol. 2024, 22:154. 10.1186\/s12958-024-01322-7","journal-title":"Reprod Biol Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00846-6","article-title":"Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20\u2009weeks of pregnancy in spontaneously achieved singleton pregnancies: a systematic review and meta-analysis","volume":"19","author":"Wu H","year":"2021","unstructured":"Wu H, Zhang S, Lin X, He J, Wang S, Zhou P. Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20\u2009weeks of pregnancy in spontaneously achieved singleton pregnancies: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2021, 19:165. 10.1186\/s12958-021-00846-6","journal-title":"Reprod Biol Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/abr.abr_27_20","article-title":"Evaluating the effect of utrogestan on idiopathic intrauterine growth retardation","volume":"9","author":"Mohammadi B","year":"2020","unstructured":"Mohammadi B, Matinfar M, Drees F, Shabanian S. Evaluating the effect of utrogestan on idiopathic intrauterine growth retardation. Adv Biomed Res. 2020, 9:45. 10.4103\/abr.abr_27_20","journal-title":"Adv Biomed Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/abr.abr_250_16","article-title":"Effect of dydrogesterone on the outcome of idiopathic intrauterine growth restriction: a double-blind clinical trial study","volume":"7","author":"Zarean E","year":"2018","unstructured":"Zarean E, Mostajeran F, Dayani Z. Effect of dydrogesterone on the outcome of idiopathic intrauterine growth restriction: a double-blind clinical trial study. Adv Biomed Res. 2018, 7:93. 10.4103\/abr.abr_250_16","journal-title":"Adv Biomed Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5455\/2320-1770.ijrcog20130609","article-title":"Role of dydrogesterone in the treatment of idiopathic IUGR","volume":"157","author":"Wadhwa L","year":"2013","unstructured":"Wadhwa L, Batra S, Tempe A. Role of dydrogesterone in the treatment of idiopathic IUGR. Int J Reprod Contracept Obstet Gynecol. 2013, 157:60. 10.5455\/2320-1770.ijrcog20130609","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-023-01249-1","article-title":"Adjuvant treatment with oral dydrogesterone in the prevention of preterm labor: a randomized, double-blinded, placebo-controlled trial","volume":"30","author":"Keshtmandi H","year":"2023","unstructured":"Keshtmandi H, Mirmohammadkhani M, Rahmanian M. Adjuvant treatment with oral dydrogesterone in the prevention of preterm labor: a randomized, double-blinded, placebo-controlled trial. Reprod Sci. 2023, 30:3037-45. 10.1007\/s43032-023-01249-1","journal-title":"Reprod Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2024.2333929","article-title":"Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Kuptarak A","year":"2024","unstructured":"Kuptarak A, Phupong V. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial. J Matern Fetal Neonatal Med. 2024, 37:2333929. 10.1080\/14767058.2024.2333929","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2011.08.006","article-title":"Dydrogesterone supplementation in women with threatened preterm delivery - the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor","volume":"92","author":"Hudi\u0107 I","year":"2011","unstructured":"Hudi\u0107 I, Szekeres-Bartho J, Fatu\u0161i\u0107 Z, et al.. Dydrogesterone supplementation in women with threatened preterm delivery - the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor. J Reprod Immunol. 2011, 92:103-7. 10.1016\/j.jri.2011.08.006","journal-title":"J Reprod Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5812\/fga-148441","article-title":"Comparison of the effect of oral dydrogesterone with oral nifedipine on the treatment of threatened preterm labor: a randomized controlled trial","volume":"4","author":"Hemmati Z","year":"2024","unstructured":"Hemmati Z, Hashemi N, Gharooni M, Soleimani Z, Rokhgireh S, Derakhshan R, Derakhshan P. Comparison of the effect of oral dydrogesterone with oral nifedipine on the treatment of threatened preterm labor: a randomized controlled trial. Fertil Gynecol Androl. 2024, 4:e148441. 10.5812\/fga-148441","journal-title":"Fertil Gynecol Androl"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04509-1","article-title":"Comparison of oral dydrogesterone and 17-\u03b1\u00a0hydroxyprogesterone\u00a0caprate\u00a0in the prevention of preterm birth","volume":"22","author":"Alizadeh F","year":"2022","unstructured":"Alizadeh F, Mahmoudinia M, Mirteimoori M, Pourali L, Niroumand S. Comparison of oral dydrogesterone and 17-\u03b1\u00a0hydroxyprogesterone\u00a0caprate\u00a0in the prevention of preterm birth. BMC Pregnancy Childbirth. 2022, 22:167. 10.1186\/s12884-022-04509-1","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/srep20638","article-title":"A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor","volume":"6","author":"Areeruk W","year":"2016","unstructured":"Areeruk W, Phupong V. A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor. Sci Rep. 2016, 6:20638. 10.1038\/srep20638","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/jog.12456","article-title":"Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study","volume":"40","author":"Ghosh S","year":"2014","unstructured":"Ghosh S, Chattopadhyay R, Goswami S, Chaudhury K, Chakravarty B, Ganesh A. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study. J Obstet Gynaecol Res. 2014, 40:1871-6. 10.1111\/jog.12456","journal-title":"J Obstet Gynaecol Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72016","article-title":"Real-world evidence of dydrogesterone 20 mg and 30 mg SR usage in pregnancy","volume":"16","author":"Manickavasagam M","year":"2024","unstructured":"Manickavasagam M, Vakil A, Singh E, et al.. Real-world evidence of dydrogesterone 20 mg and 30 mg SR usage in pregnancy. Cureus. 2024, 16:e72016. 10.7759\/cureus.72016","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoae072","article-title":"Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase)","volume":"2025","author":"Henry A","year":"2025","unstructured":"Henry A, Santulli P, Bourdon M, et al.. Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase). Hum Reprod Open. 2025, 2025:hoae072. 10.1093\/hropen\/hoae072","journal-title":"Hum Reprod Open"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051827","article-title":"Prevention of pregnancy loss: combining progestogen treatment and psychological support","volume":"12","author":"Tetruashvili N","year":"2023","unstructured":"Tetruashvili N, Domar A, Bashiri A. Prevention of pregnancy loss: combining progestogen treatment and psychological support. J Clin Med. 2023, 12:1827. 10.3390\/jcm12051827","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-012-0339-z","article-title":"The effect of high doses of folic acid and iron supplementation in early-to-mid pregnancy on prematurity and fetal growth retardation: the mother-child cohort study in Crete, Greece (Rhea study)","volume":"52","author":"Papadopoulou E","year":"2013","unstructured":"Papadopoulou E, Stratakis N, Roumeliotaki T, Sarri K, Merlo DF, Kogevinas M, Chatzi L. The effect of high doses of folic acid and iron supplementation in early-to-mid pregnancy on prematurity and fetal growth retardation: the mother-child cohort study in Crete, Greece (Rhea study). Eur J Nutr. 2013, 52:327-36. 10.1007\/s00394-012-0339-z","journal-title":"Eur J Nutr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20242813","article-title":"Dydrogesterone use in recurrent pregnancy loss and luteal phase insufficiency: a knowledge, attitude, and practice survey amongst Indian obstetricians and gynaecologists","volume":"13","author":"Tank J","year":"2024","unstructured":"Tank J, Gupte S, Mahapatra PC, et al.. Dydrogesterone use in recurrent pregnancy loss and luteal phase insufficiency: a knowledge, attitude, and practice survey amongst Indian obstetricians and gynaecologists. Int J Reprod Contracept Obstet Gynecol. 2024, 13:2795-800. 10.18203\/2320-1770.ijrcog20242813","journal-title":"Int J Reprod Contracept Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395028-efficacy-of-oral-dydrogesterone-in-improving-neonatal-birth-weight-outcomes-in-idiopathic-intrauterine-growth-restriction-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T09:31:06Z","timestamp":1755682266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395028-efficacy-of-oral-dydrogesterone-in-improving-neonatal-birth-weight-outcomes-in-idiopathic-intrauterine-growth-restriction-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.90552","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}